Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia
Supraventricular tachycardia Microchapters |
Differentiating Among the Different Types of Supraventricular Tachycardia |
---|
Differentiating Supraventricular Tachycardia from Ventricular Tachycardia |
Diagnosis |
Treatment |
2015 ACC/AHA Guideline Recommendations |
Case Studies |
Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia On the Web |
American Roentgen Ray Society Images of Supraventricular tachycardia AHA recommendations for Management of Suspected Focal Atrial Tachycardia |
Directions to Hospitals Treating Supraventricular tachycardia |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Aysha Anwar, M.B.B.S[2]
Overview
Management of Suspected Focal Atrial Tachycardia
2015 AHA recommendations for the acute and ongoing management of suspected focal atrial tachycardia are described below:
Acute treatment of Suspected Focal Atrial Tachycardia
Class I |
"1.Intravenous beta blockers, diltiazem, or verapamil is useful for acute treatment in hemodynamically stable patients with focal AT ("(Level of Evidence: C-LD) " |
"2.Synchronized cardioversion is recommended for acute treatment in patients with hemodynamically unstable focal AT("(Level of Evidence: C-LD) " |
Class IIa |
"1.Adenosine can be useful in the acute setting to either restore sinus rhythm or diagnose the tachycardia mechanism in patients with suspected focal AT "(Level of Evidence: B-NR) " |
Class IIb |
"1.Intravenous amiodarone may be reasonable in the acute setting to either restore sinus rhythm or slow the ventricular rate in hemodynamically stable patients with focal A "(Level of Evidence:C-LD) " |
"2.Ibutilide may be reasonable in the acute setting to restore sinus rhythm in hemodynamically stable patients with focal AT( "(Level of Evidence: C-LD) " |
Management of ongoing Suspected Focal Atrial Tachycardia
Class I |
"1.Catheter ablation is recommended in patients with symptomatic focal AT as an alternative to pharmacological therapy ( "(Level of Evidence: B-NR) " |
Class IIa |
"1.Oral beta blockers, diltiazem, or verapamil are reasonable for ongoing management in patients with symptomatic focal AT "(Level of Evidence: C-LD) " |
"2.Flecainide or propafenone can be effective for ongoing management in patients without structural heart disease or ischemic heart disease who have focal AT"(Level of Evidence: C-LD) " |
Class IIb |
"1.Oral sotalol or amiodarone may be reasonable for ongoing management in patients with focal AT "(Level of Evidence:C-LD) " |